<DOC>
	<DOCNO>NCT00001571</DOCNO>
	<brief_summary>Non-Hodgkin 's lymphoma ( NHL ) third rapidly increase cancer United States . HIV-related NHL responsible increase since early 1980s . However , explain steady increase incidence rate earlier year , entire increase show recently . A possible role environmental exposure receive attention . One possibility exposure organochlorines ( OCs ) may relate occurrence NHL . NCI currently design large population-based case-control study investigate hypothesis analyze OC level blood collect time interview case NHL match control . At time interview , case main case-control study would likely already receive chemotherapy . If chemotherapy change blood level OCs , may lead misclassification exposure among case eventually bias risk estimate . The purpose pilot study estimate bias due measure serum level OCs case chemotherapy . Twenty newly diagnose patient recruit study . From patient , four consecutive blood sample , one prior , two , one chemotherapy , collect . Forty pair pre-existing cryopreserved serum sample ( pre- post-treatment ) take NHL patient participate earlier NCI clinical study also include study . Samples assay OC level . The result use plan interpret another large case-control study ( main study ) .</brief_summary>
	<brief_title>A Pilot Study Non-Hodgkin 's Lymphoma : Chemotherapy Blood Levels Organochlorines</brief_title>
	<detailed_description>Non-Hodgkin 's lymphoma ( NHL ) third rapidly increase cancer United States . HIV-related NHL responsible increase since early 1980s . However , explain steady increase incidence rate earlier year , entire increase show recently . A possible role environmental exposure receive attention . One possibility exposure organochlorines ( OCs ) may relate occurrence NHL . NCI currently design large population-based case-control study investigate hypothesis analyze OC level blood collect time interview case NHL match control . At time interview , case main case-control study would likely already receive chemotherapy . If chemotherapy change blood level OCs , may lead misclassification exposure among case eventually bias risk estimate . The purpose pilot study estimate bias due measure serum level OCs case chemotherapy . Twenty newly diagnose patient recruit study . From patient , four consecutive blood sample , one prior , two , one chemotherapy , collect . Forty pair pre-existing cryopreserved serum sample ( pre- post-treatment ) take NHL patient participate earlier NCI clinical study also include study . Samples assay OC level . The result use plan interpret another large case-control study ( main study ) .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , AIDS-Related</mesh_term>
	<criteria>All NHL patient previously receive chemotherapy admit NCI Clinical Center enrol trail eligible study . All histological subtypes stage . Any NHL patient age 20 74 . Must able give inform consent . No NHL patient HIV positive include .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>Cancer</keyword>
	<keyword>DDT , PCB</keyword>
	<keyword>Epidemiology</keyword>
	<keyword>Pesticides</keyword>
	<keyword>Serum</keyword>
</DOC>